Vaso-vagal Syncope (VVS) after Mydriatic Eyedrops in Cutaneous and Intracranial Vascular Deformations (Pascual-Castroviejo Syndrome Type II)
Purpose: To present a case of vaso-vagal syncope (VVS) after mydriatic eye drops in a patient with cutaneous hemangioma and intracerebral vascular abnormalities. Case report: A 41-year old woman presented to an ophthalmology clinic complaining of near vision disturbance. On examination...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Pan-American Association of Ophthalmology
2017-04-01
|
Series: | Vision Pan-America |
Subjects: | |
Online Access: | http://journals.sfu.ca/paao/index.php/journal/article/view/405 |
Summary: | Purpose: To present a case of vaso-vagal
syncope (VVS) after mydriatic eye drops in a
patient with cutaneous hemangioma and
intracerebral vascular abnormalities.
Case report: A 41-year old woman
presented to an ophthalmology clinic
complaining of near vision disturbance.
On examination, there was dilatation and
telangiectasis of the conjunctival vessels
on the temporal side of the right eye
associated with right hemicranial and
neck cutaneous involuted hemangioma
ipsilateral to the conjunctival lesion. The
patient experienced vaso-vagal syncope for
approximately 15 minutes after mydriatic
eye drops, 2 months prior to presentation.
A magnetic resonance angiogram (MRA)
showed right hypoplasia of the lateral
and sigmoideus venous sinus ipsilateral
to the external right hemangioma with
predominantly compensatory drainage
at the contralateral left system. At the
neck vessels, the MRA showed dominant
drainage through the lateral and jugular left
sinus by the hypoplasia of the contralateral
right system.
Conclusion: This case shows the
association of telangiectasis of the
conjunctiva, and cutaneous hemangiomas
of the head and neck with anomalies
involving the central nervous system (CNS)
as described by Pascual-Castroviejo in 1978,
which they called cutaneous hemangioma–
vascular complex syndrome. The diagnosis
was made after the patient experienced
VVS after mydriatic eyedrops instillation. |
---|---|
ISSN: | 2219-4665 2219-4673 |